373 related articles for article (PubMed ID: 31563654)
1. Endovascular Revascularization Incorporating Infrapopliteal Coronary Drug-Eluting Stents Improves Clinical Outcomes in Patients with Critical Limb Ischemia and Tissue Loss.
Huntress LA; Fereydooni A; Dardik A; Nassiri N
Ann Vasc Surg; 2020 Feb; 63():234-240. PubMed ID: 31563654
[TBL] [Abstract][Full Text] [Related]
2. Use of drug-eluting stents in patients with critical limb ischemia and infrapopliteal arterial disease: a real-world single-center experience.
AbuRahma AF; Beasley M; Davis M; Adams E; Lee A; Shapiro J; Dean LS; Davis E
J Vasc Surg; 2021 Nov; 74(5):1619-1625. PubMed ID: 34182023
[TBL] [Abstract][Full Text] [Related]
3. Everolimus-Eluting Stent for Patients With Critical Limb Ischemia and Infrapopliteal Arterial Occlusive Disease.
Giaquinta A; Vincenzo A; De Marco E; Veroux M; Veroux P
Vasc Endovascular Surg; 2017 Feb; 51(2):60-66. PubMed ID: 28100126
[TBL] [Abstract][Full Text] [Related]
4. Amputation-free Survival in Patients with Critical Limb Ischemia Treated with Paclitaxel-eluting Stents and Paclitaxel-coated Balloons.
Phair J; Carnevale M; Lipsitz EC; Shariff S; Scher L; Garg K
Ann Vasc Surg; 2020 Jan; 62():8-14. PubMed ID: 31207400
[TBL] [Abstract][Full Text] [Related]
5. One-Year Outcomes of the Paclitaxel-Eluting, Self-Expanding Stentys Stent System in the Treatment of Infrapopliteal Lesions in Patients With Critical Limb Ischemia.
Bosiers M; Callaert J; Keirse K; Hendriks JMH; Peeters P; Verbist J; Maene L; Beelen R; Deloose K
J Endovasc Ther; 2017 Jun; 24(3):311-316. PubMed ID: 28351310
[TBL] [Abstract][Full Text] [Related]
6. WIfI Classification Versus Angiosome Concept: A Change in the Infrapopliteal Angioplasties Paradigm.
de Athayde Soares R; Matielo MF; Brochado Neto FC; Veloso de Melo B; Maia Pires AP; Tiossi SR; Godoy MR; Sacilotto R
Ann Vasc Surg; 2021 Feb; 71():338-345. PubMed ID: 32800883
[TBL] [Abstract][Full Text] [Related]
7. Predictive ability of the Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classification system following infrapopliteal endovascular interventions for critical limb ischemia.
Darling JD; McCallum JC; Soden PA; Meng Y; Wyers MC; Hamdan AD; Verhagen HJ; Schermerhorn ML
J Vasc Surg; 2016 Sep; 64(3):616-22. PubMed ID: 27380993
[TBL] [Abstract][Full Text] [Related]
8. Midterm Outcomes After Infrapopliteal Interventions in Patients With Critical Limb Ischemia Based on the TASC II Classification of Below-the-Knee Arteries.
Singh GD; Brinza EK; Hildebrand J; Waldo SW; Foley TR; Laird JR; Armstrong EJ
J Endovasc Ther; 2017 Jun; 24(3):321-330. PubMed ID: 28421855
[TBL] [Abstract][Full Text] [Related]
9. Primary Self-EXPANDing Nitinol Stenting vs Balloon Angioplasty With Optional Bailout Stenting for the Treatment of Infrapopliteal Artery Disease in Patients With Severe Intermittent Claudication or Critical Limb Ischemia (EXPAND Study).
Schulte KL; Pilger E; Schellong S; Tan KT; Baumann F; Langhoff R; Torsello G; Zeller T; Amendt K; Brodmann M;
J Endovasc Ther; 2015 Oct; 22(5):690-7. PubMed ID: 26245919
[TBL] [Abstract][Full Text] [Related]
10. Society for Vascular Surgery Wound, Ischemia, foot Infection (WIfI) score correlates with the intensity of multimodal limb treatment and patient-centered outcomes in patients with threatened limbs managed in a limb preservation center.
Robinson WP; Loretz L; Hanesian C; Flahive J; Bostrom J; Lunig N; Schanzer A; Messina L
J Vasc Surg; 2017 Aug; 66(2):488-498.e2. PubMed ID: 28410924
[TBL] [Abstract][Full Text] [Related]
11. Peroneal bypass versus endovascular peroneal intervention for critical limb ischemia.
Mohapatra A; Boitet A; Malak O; Henry JC; Avgerinos ED; Makaroun MS; Hager ES; Chaer RA
J Vasc Surg; 2019 Jan; 69(1):148-155. PubMed ID: 30580779
[TBL] [Abstract][Full Text] [Related]
12. Real-World Performance of Paclitaxel Drug-Eluting Bare Metal Stenting (Zilver PTX) for the Treatment of Femoropopliteal Occlusive Disease.
Tran K; Ullery BW; Kret MR; Lee JT
Ann Vasc Surg; 2017 Jan; 38():90-98. PubMed ID: 27554688
[TBL] [Abstract][Full Text] [Related]
13. Multilevel versus isolated endovascular tibial interventions for critical limb ischemia.
Fernandez N; McEnaney R; Marone LK; Rhee RY; Leers S; Makaroun M; Chaer RA
J Vasc Surg; 2011 Sep; 54(3):722-9. PubMed ID: 21803523
[TBL] [Abstract][Full Text] [Related]
14. A systematic review and meta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemia.
Almasri J; Adusumalli J; Asi N; Lakis S; Alsawas M; Prokop LJ; Bradbury A; Kolh P; Conte MS; Murad MH
J Vasc Surg; 2019 Jun; 69(6S):126S-136S. PubMed ID: 31159976
[TBL] [Abstract][Full Text] [Related]
15. Major adverse limb events and wound healing following infrapopliteal artery stent implantation in patients with critical limb ischemia: the XCELL trial.
Rocha-Singh KJ; Jaff M; Joye J; Laird J; Ansel G; Schneider P;
Catheter Cardiovasc Interv; 2012 Nov; 80(6):1042-51. PubMed ID: 22605682
[TBL] [Abstract][Full Text] [Related]
16. Early and Midterm Experience With the Absorb Everolimus-Eluting Bioresorbable Vascular Scaffold in Asian Patients With Chronic Limb-Threatening Ischemia: One-Year Clinical and Imaging Outcomes From the DISAPEAR Registry.
Kum S; Ipema J; Chun-Yin DH; Lim DM; Tan YK; Varcoe RL; Hazenberg CEVB; Ünlü Ç
J Endovasc Ther; 2020 Aug; 27(4):616-622. PubMed ID: 32469296
[No Abstract] [Full Text] [Related]
17. Long-term outcomes following primary drug-eluting stenting of infrapopliteal bifurcations.
Spiliopoulos S; Fragkos G; Katsanos K; Diamantopoulos A; Karnabatidis D; Siablis D
J Endovasc Ther; 2012 Dec; 19(6):788-96. PubMed ID: 23210878
[TBL] [Abstract][Full Text] [Related]
18. Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease.
Bosiers M; Scheinert D; Peeters P; Torsello G; Zeller T; Deloose K; Schmidt A; Tessarek J; Vinck E; Schwartz LB
J Vasc Surg; 2012 Feb; 55(2):390-8. PubMed ID: 22169682
[TBL] [Abstract][Full Text] [Related]
19. Major Limb Outcomes Following Lower Extremity Endovascular Revascularization in Patients With and Without Diabetes Mellitus.
Shammas AN; Jeon-Slaughter H; Tsai S; Khalili H; Ali M; Xu H; Rodriguez G; Cawich I; Armstrong EJ; Brilakis ES; Banerjee S
J Endovasc Ther; 2017 Jun; 24(3):376-382. PubMed ID: 28440113
[TBL] [Abstract][Full Text] [Related]
20. Outcomes After Drug-Coated Balloon Treatment of Femoropopliteal Lesions in Patients With Critical Limb Ischemia: A Post Hoc Analysis From the IN.PACT Global Study.
Reijnen MMPJ; van Wijck I; Zeller T; Micari A; Veroux P; Keirse K; Lee SW; Li P; Voulgaraki D; Holewijn S
J Endovasc Ther; 2019 Jun; 26(3):305-315. PubMed ID: 30931726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
